Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122549 · ClinicalTrials.gov registry record · NA
Hospital Wearable Defibrillator Inpatient Study
A NA study of In-hospital Cardiac Arrest, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 8
- Study locations
NCT02122549 is a NA study of In-hospital Cardiac Arrest that has completed, run by Zoll Medical Corporation. The registered enrollment target is 59 participants. The trial reports 8 study locations across 7 states.
The verdict
NCT02122549, a NA study of In-hospital Cardiac Arrest, has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 8
- Study locations
Study Summary
This study will obtain device-human interaction evaluations for the HWD1000 within the controlled environment of the hospital as well as establish that the safety profile is similar to outpatient wearable cardioverter-defibrillators use.
Conditions Studied
Interventions
- DEVICE HWD1000
Study Locations (8)
Florida
- - Atlantis
- - Jupiter
California
- - Los Angeles
Connecticut
- - Danbury
Iowa
- - Iowa City
Minnesota
- - Saint Paul
Virginia
- - Richmond
Washington
- - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02122549
The ClinicalTrials.gov registry entry for NCT02122549 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with In-hospital Cardiac Arrest appearing as the primary indexed condition, and to 1 intervention - of which HWD1000 is the first listed.
NCT02122549 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT02122549 about?
NCT02122549 is a clinical study titled "Hospital Wearable Defibrillator Inpatient Study". This study will obtain device-human interaction evaluations for the HWD1000 within the controlled environment of the hospital as well as establish that the safety profile is similar to outpatient wearable cardioverter-defibrillators use.
What is the current status of trial NCT02122549?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2014-04. Estimated completion is 2015-07.
What conditions does trial NCT02122549 study?
This clinical trial studies the following conditions: In-hospital Cardiac Arrest.
What interventions are being tested in trial NCT02122549?
The interventions under investigation include: HWD1000 (DEVICE).
Who is sponsoring clinical trial NCT02122549?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02122549 being conducted?
This trial has 8 study locations across California, Connecticut, Florida, Iowa, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for In-hospital Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.